Featured Research

from universities, journals, and other organizations

Rate of women with pregnancy-associated cancer on the rise, study suggests

Date:
September 4, 2012
Source:
Wiley
Summary:
The rate of pregnancy-associated cancer is increasing and is only partially explained by the rise in older mothers, suggests new research.

The rate of pregnancy-associated cancer is increasing and is only partially explained by the rise in older mothers suggests new research published in BJOG: An International Journal of Obstetrics and Gynaecology.

A large Australian study looked at 781,907 women who gave birth in New South Wales (NSW) between 1994 and 2008 which corresponds to 1,309,501 maternities. Women with pregnancy-associated cancer, where the initial diagnosis of cancer is made during pregnancy or within 12 months of delivery, are compared to women without cancer.

A total of 1,798 pregnancy-associated cancers were identified from the total number of maternities corresponding to an overall incidence rate of 137.3 per 100,000 maternities. The research found that between 1994 and 2008 the incidence rate of pregnancy-associated cancer increased from 112.3 to 191.5 per 100,000 maternities.

During this period maternal age also increased. The percentage of women aged 35 years and over increased from 13.2% to 23.6% in New South Wales.

Despite this the research found that only 14% of the increase was explained by increasing maternal age. The research looked at independent risk factors for pregnancy-associated cancer including older maternal age, Australian-born, socio-economic status, multiparity, multiple pregnancy and prior diagnosis of cancer.

The authors state that improved diagnostic techniques, detection and increased interaction with health services during pregnancy may contribute to higher incidence rates of pregnancy-associated cancer. They also say that the genetic and environmental origins of pregnancy-associated cancers are likely to pre-date the pregnancy, however the hormones and growth factors necessary for fetal growth may accelerate tumour growth.

The most common cancers were melanoma of skin, breast cancer, thyroid and other endocrine cancers, gynaecological and lymphohaematopoeitic cancers. However it must be noted that Australia has the highest incidence of melanoma in the world.

In addition the study looked at pregnancy outcomes and found that cancer during pregnancy was associated with a significantly increased risk of caesarean section, planned preterm birth and large-for-gestational-age infants.

Professor Christine Roberts, Clinical and Population Perinatal Health Research, Kolling Institute of Medical Research, University of Sydney, New South Wales and co-author of the paper said:

"This is a large study and looks at contemporary data. The trend for women to postpone childbearing has raised concerns about the incidence of cancer in pregnancy increasing.

"Although maternal age was a strong risk factor for cancer, increasing maternal age explained only some of the increase in cancer incidence. Pregnancy increases women's interaction with health services and the possibility for diagnosis is therefore increased. Furthermore, pregnancy may actually influence tumour growth."

John Thorp, BJOG Deputy-Editor-in-Chief added: "Pregnancy is a time when a woman comes into contact with healthcare workers more frequently than normal and this may play a part in certain cancers being picked up more. The most common cancer was melanoma of the skin which it must be noted is more common in Australia than other countries."


Story Source:

The above story is based on materials provided by Wiley. Note: Materials may be edited for content and length.


Journal Reference:

  1. YY Lee, CL Roberts, T Dobbins, E Stavrou, K Black, J Morris, J Young. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994-2008: a population-based linkage study. BJOG: An International Journal of Obstetrics & Gynaecology, 2012; DOI: 10.1111/j.1471-0528.2012.03475.x

Cite This Page:

Wiley. "Rate of women with pregnancy-associated cancer on the rise, study suggests." ScienceDaily. ScienceDaily, 4 September 2012. <www.sciencedaily.com/releases/2012/09/120904193742.htm>.
Wiley. (2012, September 4). Rate of women with pregnancy-associated cancer on the rise, study suggests. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/09/120904193742.htm
Wiley. "Rate of women with pregnancy-associated cancer on the rise, study suggests." ScienceDaily. www.sciencedaily.com/releases/2012/09/120904193742.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins